Mass spectrometry-based analysis of glycoproteins and its clinical applications in cancer biomarker discovery

被引：33
|
作者：
Liu, Huan [1 ,2 ]
Zhang, Ningbo [1 ,2 ]
Wan, Debin [1 ,2 ]
Cui, Meng [1 ]
Liu, Zhiqiang [1 ]
Liu, Shuying [1 ]
机构：
[1] Chinese Acad Sci, Changchun Inst Appl Chem, Changchun Ctr Mass Spectrometry, 5625 Renmin St, Changchun 130022, Peoples R China
[2] Univ Chinese Acad Sci, Beijing 100039, Peoples R China
来源：
CLINICAL PROTEOMICS | 2014年 / 11卷
基金：
中国国家自然科学基金;
关键词：
Mass spectrometry; Glycoproteins; Cancer biomarker; ELECTRON DETACHMENT DISSOCIATION; N-LINKED GLYCOPROTEINS; NANO-LC-MS/MS; STRUCTURAL-CHARACTERIZATION; PROTEIN GLYCOSYLATION; QUANTITATIVE-ANALYSIS; LIVER-CANCER; IDENTIFICATION; SERUM; GLYCANS;
D O I：
10.1186/1559-0275-11-14
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
Glycosylation is one of the most important posttranslational modifications of proteins and plays essential roles in various biological processes. Aberration in the glycan moieties of glycoproteins is associated with many diseases. It is especially critical to develop the rapid and sensitive methods for analysis of aberrant glycoproteins associated with diseases. Mass spectrometry (MS) has become a powerful tool for glycoprotein analysis. Especially, tandem mass spectrometry can provide highly informative fragments for structural identification of glycoproteins. This review provides an overview of the development of MS technologies and their applications in identification of abnormal glycoproteins and glycans in human serum to screen cancer biomarkers in recent years.
引用
收藏
页数：9
相关论文
共 50 条
  • [31] Mass spectrometry for glycan biomarker discovery
    Aizpurua-Olaizola, O.
    Sastre Torano, J.
    Falcon-Perez, J. M.
    Williams, C.
    Reichardt, N.
    Boons, G. -J.
    TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2018, 100 : 7 - 14
  • [32] Frontiers in mass spectrometry-based clinical proteomics for cancer diagnosis and treatment
    Haga, Yoshimi
    Minegishi, Yuriko
    Ueda, Koji
    CANCER SCIENCE, 2023, 114 (05) : 1783 - 1791
  • [33] Mass Spectrometry-Based Analysis for the Discovery and Validation of Potential Colorectal Cancer Stool Biomarkers
    Ang, C. S.
    Baker, M. S.
    Nice, E. C.
    PROTEOMICS IN BIOLOGY, PT B, 2017, 586 : 247 - 274
  • [34] Mass spectrometry-based immunoassays for the next phase of clinical applications
    Nedelkov, Dobrin
    EXPERT REVIEW OF PROTEOMICS, 2006, 3 (06) : 631 - 640
  • [35] MALDI mass spectrometry in prostate cancer biomarker discovery
    Flatley, Brian
    Malone, Peter
    Cramer, Rainer
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2014, 1844 (05): : 940 - 949
  • [36] Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer
    Ryu, Joohyun
    Thomas, Stefani N.
    MOLECULES, 2021, 26 (09):
  • [37] Recent advances in mass spectrometry-based proteomics of gastric cancer
    Kang, Changwon
    Lee, Yejin
    Lee, J. Eugene
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (37) : 8283 - 8293
  • [38] Mass spectrometry-based plasma proteomics: state of the art and future outlook
    Pernemalm, Maria
    Lehtio, Janne
    EXPERT REVIEW OF PROTEOMICS, 2014, 11 (04) : 431 - 448
  • [39] The evolving role of mass spectrometry in cancer biomarker discovery
    Wang, Pei
    Whiteaker, Jeffrey R.
    Paulovich, Amanda G.
    CANCER BIOLOGY & THERAPY, 2009, 8 (12) : 1083 - 1094
  • [40] Quantitative mass spectrometry-based techniques for clinical use: Biomarker identification and quantification
    Simpson, Kathryn L.
    Whetton, Anthony D.
    Dive, Caroline
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2009, 877 (13): : 1240 - 1249
12345